(Q48467671)

English

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.

scientific article published on 31 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

phase I clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Olivier Gasser

4

0 references

object named as

Ian F Hermans

11

0 references

Katrina Sharples

8

object named as

Katrina J Sharples

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

author name string

Martin K Hunn

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Evelyn Bauer

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Catherine E Wood

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Marina Dzhelali

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Lindsay R Ancelet

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Brigitta Mester

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Michael P Findlay

9

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

David A Hamilton

10

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

publication date

31 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

121

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

319-329

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

https://scigraph.springernature.com/pub.10.1007/s11060-014-1635-7

0 references

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

The efficacy of temozolomide for recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Salvage temozolomide for prior temozolomide responders

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Rechallenge with temozolomide in patients with recurrent gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Overview of cellular immunotherapy for patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Combined modality immunotherapy and chemotherapy: a new perspective

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Lineage-specific mechanism of drug and radiation resistance in melanoma mediated by tyrosinase-related protein 2.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Quantitatively determined survivin expression levels are of prognostic value in human gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

No prognostic impact of survivin expression in glioblastoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

EGFRvIII-targeted vaccination therapy of malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

T cell immunity induced by live, necrotic, and apoptotic tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Human monocytes undergo excessive apoptosis following temozolomide activating the ATM/ATR pathway while dendritic cells and macrophages are resistant

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Dendritic cell immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1635-7

21 January 2018

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular-based immunotherapies for patients with glioblastoma multiforme.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of tyrosinase, TRP-1 and TRP-2 in ultraviolet-irradiated human melanomas and melanocytes: TRP-2 protects melanoma cells from ultraviolet B induced apoptosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://pubmed.ncbi.nlm.nih.gov/25366363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-014-1635-7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/25366363

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48467671&oldid=1790314903"